Lowrie Richard, Paudyal Vibhu, McPherson Andrew, Heath Helena, Moir Jane, Allen Natalie, Barnes Nigel, Hill Hugh, Araf Adnan, Lombard Cian, Ross Steven, Tearne Sarah, Jagpal Parbir, Cheed Versha, Middleton Lee, Akhtar Shabana, Provan George, Hislop Jennifer, Williamson Andrea, Mair Frances S
Centre for Homelessness and Inclusion Health, School of Health in Social Science, University of Edinburgh, Edinburgh, UK.
Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
J Urban Health. 2025 Jun 9. doi: 10.1007/s11524-025-00981-0.
Randomized controlled trials (RCTs) aiming to address the multiple health and social challenges of people experiencing homelessness (PEH) are lacking. Here we report the findings from a multicenter, open, pilot RCT. The intervention involved independent prescriber pharmacist from the National Health Service working on outreach in partnership with dedicated workers from Homeless Voluntary Charity or Social Enterprises (HVCSEs) (Pharmacist and third sector charity worker integrated Homeless Outreach Engagement Non-medical Independent prescriber Rx'-PHOENIx) in low threshold HVCSE venues or temporary accommodation addressing PEH participants' health and wider needs through repeated outreach. The trial aimed to investigate whether sufficient numbers of participants could be recruited, retained, the intervention delivered as planned, and sufficient data collected to inform a subsequent definitive RCT. Clinical outcomes were also collected at follow-up (6 months). Participants were recruited from five community pharmacies and nearby venues in urban centers of Glasgow-Scotland and Birmingham-England, then randomized one-to-one into PHOENIx intervention in addition to usual care (UC) or UC only. A priori progression criteria were achieved: 55% of those assessed as eligible were recruited; at 6 months, 72% remained in the study, 91% had emergency department and mortality data available, and 72% completed questionnaire booklets. Fifty-three percent of participants received at least 50% of the planned PHOENIx intervention consultations (in-person or phone) at 6 months. Signs of improvement in clinical outcomes in the PHOENIx group included fewer ambulance call-outs, ED visits, and hospitalizations; higher outpatient attendances; and higher scores on self-reported health-related quality of life. A definitive RCT is merited.
旨在应对无家可归者所面临的多重健康和社会挑战的随机对照试验(RCT)尚属欠缺。在此,我们报告一项多中心、开放性试点RCT的结果。干预措施包括来自国民医疗服务体系的独立处方药剂师与无家可归者志愿慈善机构或社会企业(HVCSEs)的专职工作人员合作开展外展服务(药剂师与第三部门慈善工作者整合的无家可归者外展参与非医疗独立处方者Rx'-PHOENIx),在低门槛的HVCSE场所或临时住所通过反复外展服务来满足无家可归参与者的健康及更广泛需求。该试验旨在调查是否能够招募到足够数量的参与者并使其留存,干预措施能否按计划实施,以及能否收集到足够的数据以支持后续的确证性RCT。随访时(6个月)也收集了临床结局。参与者从苏格兰格拉斯哥和英格兰伯明翰市中心的五家社区药房及附近场所招募,然后一对一随机分为接受PHOENIx干预加常规护理(UC)组或仅接受UC组。达到了预先设定的进展标准:55%被评估为符合条件的人被招募;6个月时,72%仍留在研究中,91%有急诊科和死亡率数据,72%完成了问卷小册子。53%的参与者在6个月时接受了至少50%计划的PHOENIx干预咨询(面对面或电话)。PHOENIx组临床结局改善的迹象包括更少的救护车出诊、急诊科就诊和住院;更高的门诊就诊率;以及自我报告的健康相关生活质量得分更高。确有必要开展一项确证性RCT。